Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OnabotulinumtoxinA vs aluminium chloride for residual limb hyperhidrosis (lower limbs)
2014-002068-34Phase 3Active
- Sponsor
- French Defence Health Service
- Start
- Jul 2015
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of botulinum toxin type A in hyperhidrosis (2 arms), sponsored by French Defence Health Service. Primary endpoint: Decrease in Hyperhidrosis Disease Severity Scale (HDSS) score. Started Jul 2015; status: active.
02
Drugs
botulinum toxin type A
03
Conditions
hyperhidrosis
Beyond the preview
Go deeper on 2014-002068-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-002068-34.